Lantheus Holdings (LNTH) Free Cash Flow (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Free Cash Flow came in at $121.9 million in Q1 2026, up 19.85% year-on-year from $101.7 million in Q1 2025, and up 105.2% on a QoQ basis from $59.4 million in Q4 2025.
Lantheus Holdings (LNTH) Free Cash Flow (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Free Cash Flow data on file, last reported at $121.9 million in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 19.85% year-over-year to $121.9 million in Q1 2026; TTM through Mar 2026 was $374.2 million, a 28.17% decrease from a year earlier, with the FY2025 full-year figure at $354.1 million, down 34.4% from the prior year.
- Free Cash Flow for Q1 2026 stood at $121.9 million, up from $59.4 million in the prior quarter.
- Over the last five years, Free Cash Flow for LNTH reached as high as $233.6 million in Q4 2024 and fell as low as -$43.7 million in Q2 2023.
- Historically, Free Cash Flow has averaged $92.8 million across 5 years, with a median of $100.0 million in 2025.
- Across the five-year window, Free Cash Flow surged 4874.56% in 2022 and plunged 164.01% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at $87.0 million in 2022, then surged by 73.16% to $150.7 million in 2023, then surged by 55.05% to $233.6 million in 2024, then tumbled by 74.57% to $59.4 million in 2025, then jumped by 105.2% to $121.9 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $121.9 million in Q1 2026, $59.4 million in Q4 2025, and $100.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 121.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.90 Mn |
| Mar 31, 2026 | 121.90 Mn |
| Dec 31, 2025 | 59.41 Mn |
| Dec 31, 2025 | 59.41 Mn |
| Sep 30, 2025 | 99.98 Mn |
| Sep 30, 2025 | 99.98 Mn |
| Jun 30, 2025 | 92.96 Mn |
| Jun 30, 2025 | 92.96 Mn |
| Mar 31, 2025 | 101.71 Mn |
| Mar 31, 2025 | 101.71 Mn |
| Dec 31, 2024 | 233.58 Mn |
| Dec 31, 2024 | 233.58 Mn |
| Sep 30, 2024 | 128.06 Mn |
| Sep 30, 2024 | 128.06 Mn |
| Jun 30, 2024 | 57.66 Mn |
| Jun 30, 2024 | 57.66 Mn |
| Mar 31, 2024 | 120.39 Mn |
| Mar 31, 2024 | 120.39 Mn |
| Dec 31, 2023 | 150.65 Mn |
| Dec 31, 2023 | 150.65 Mn |